CD86 and glioblastoma: PDT-treated human GBM cells and murine GBM models induce DC maturation [17,18,29,30], as evidenced by changes in the expression of surface markers such as CDD83+ [49], CD40+ [55], CD 80+, CD86+ [56], and OX-6 (MHC-II) [57].